US 11248056
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 11248056 (Muscle targeting complexes and uses thereof for treating dystrophinopathies) held by Dyne Therapeutics, Inc. expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61K47/10, A61K47/549